Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

Right Now

Africa HIV Drugs Market
Comprehensive Analysis and Forecast 2024 to 2030


Africa HIV Drugs Market Overview: 2024-2030

Base Year: 2023

Historical Years:  2019-22

Forecast Years: 2024-2030

The Africa HIV
Drugs Market size is estimated to grow at a CAGR of around 8.20% during the
forecast period, i.e., 2024-30. The Africa
HIV Drugs Market
is going through significant growth due to multiple
drivers like technological advancements and, of course, increasing healthcare
needs. The increase in road accidents throughout the country creates a greater
demand for X-rays.

Markntel
Advisor’s Africa HIV Drugs Market
Insights report provides the current and forecast market analysis, individual
leading companies' market shares, challenges, Africa HIV Drugs Market drivers,
barriers, Africa HIV Drugs Market Trends, and Key Players in Africa HIV Drugs
Market.

Our Latest Reports Now Include In-Depth
Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff
Challenges with Greater Agility Get Sample Report - This paragraph to be added
on Request sample Line and after then add  
LINK
OF SAMPLE

Africa HIV Drugs Market Dynamics: 2024-2030

Africa HIV Drugs Market Challenge:

High Cost of HIV Drugs to Hinder Market
Growth & Expansion –

The high cost of HIV drugs in the African market remains a formidable
challenge, impeding widespread access to life-saving medication. For instance,

 

In 2023, the
South African Health Department mentioned that the cost of ViiV Healthcare’s
HIV drug Apretude, which is between USD 28.9 to USD 30.5 after the prices had
been reduced by the company, is still three times higher than its people can
afford to pay.

This high cost
has been attributed to the region’s limited healthcare budgets, the presence of
only a few local and regional HIV drug manufacturing companies, huge dependency
on imported HIV drugs that are patent protected, and dependence on donor
funding, among others. Hence, Africa’s huge dependency on imported medications,
including HIV drugs, has been contributing to its high cost. The high cost of
HIV drugs makes them unaffordable and inaccessible to people, specifically
those from lower economic sections. Hence has been hampering the demand for HIV
drugs in the region.

Browse
Full Report with Detail Analysis –
https://www.marknteladvisors.com/research-library/africa-hiv-drugs-market.html
 

Africa HIV Drugs Market (2024-30):
Segmentation Outlook

The market
report has segmented the market into the following categories:

By Drug Class

-Nucleoside
Reverse Transcriptase Inhibitors (NRTIs)- Market Size & Forecast 2019-2030,
USD Million

-Non-nucleoside
Reverse Transcriptase Inhibitors (NNRTIs)- Market Size & Forecast
2019-2030, USD Million

-Protease
Inhibitors- Market Size & Forecast 2019-2030, USD Million

-Integrase
Inhibitors- Market Size & Forecast 2019-2030, USD Million

-Fusion Inhibitors-Vector-
Market Size & Forecast 2019-2030, USD Million

-Coreceptor
Antagonists- Market Size & Forecast 2019-2030, USD Million

-Combination HIV
Drugs- Market Size & Forecast 2019-2030, USD Million

-Others
(Pharmacokinetic Enhancers, Capsid Inhibitors, etc.)- Market Size &
Forecast 2019-2030, USD Million

By Route of Administration

-Oral Drugs-
Market Size & Forecast 2019-2030, USD Million

-Injectable
Drugs- Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

-Hospital
Pharmacies - Market Size & Forecast 2019-2030, USD Million

-Retail
Pharmacies- Market Size & Forecast 2019-2030, USD Million

-Online
Pharmacies- Market Size & Forecast 2019-2030, USD Million

By Country

-South Africa

-Algeria

-Nigeria

-Kenya

-Uganda

-Rest of Africa.

Note - If there are any particular
details you need that are not currently included in the report, we will be
happy to provide them as part of our
customization
services
.

Top Companies Operating in the Africa HIV
Drugs Market:

Aurobindo
Pharma, ViiV Healthcare group of companies, Johnson & Johnson Services,
Inc., Merck & Co., Inc., Cipla Inc., Bristol-Myers Squibb Company, AbbVie
Inc., Gilead Sciences, Inc., Aspen Holdings, Cosmos Limited, and others.

Reports Delivery
Format - Market research studies from MarkNtel Advisors are offered in PDF,
Excel, and PowerPoint formats. Within 24 hours of the payment being
successfully received, the report will be sent to your email address

About Us –

We are a leading
market research company, consulting, & data analytics firm that provides an
extensive range of strategic reports on diverse industry verticals. We deliver
data to a substantial & varied client base, including multinational
corporations, financial institutions, governments, & individuals, among
others.

Our
specialization in niche industries & emerging geographies allows our
clients to formulate their strategies in a much more informed way and entail
parameters like Go-to-Market (GTM), product development, feasibility analysis,
project scoping, market segmentation, competitive benchmarking, market sizing
& forecasting, & trend analysis, among others, for 15 diverse
industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office:
564 Prospect St, B9, New Haven, Connecticut, USA-06511



































































































Address
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301,
India

More Posts

0 comments
0 comments
0 comments
0 comments
0 comments
0 comments
0 comments
0 comments
0 comments
0 comments
0 comments
Load More wait